These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 15719703
21. Hematocrit influences immunoassay performance for the measurement of tacrolimus in whole blood. Armendáriz Y, García S, Lopez RM, Pou L. Ther Drug Monit; 2005 Dec; 27(6):766-9. PubMed ID: 16306852 [Abstract] [Full Text] [Related]
22. Analysis of factors influencing tacrolimus levels and immunoassay bias in renal transplantation. Borrows R, Chusney G, Loucaidou M, James A, Goel S, Borrows S, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D. J Clin Pharmacol; 2007 Aug; 47(8):1035-42. PubMed ID: 17660485 [No Abstract] [Full Text] [Related]
26. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants. Salm P, Taylor PJ, Clark A, Balderson GA, Grygotis A, Norris RL, Lynch SV, Shaw LM, Pond SM. Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113 [Abstract] [Full Text] [Related]
27. Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values. Doki K, Homma M, Hori T, Tomita T, Hasegawa Y, Ito S, Fukunaga K, Kaneko M, Chiba S, Sumida T, Ohkohchi N, Kohda Y. J Pharm Pharmacol; 2010 Sep; 62(9):1185-8. PubMed ID: 20796198 [Abstract] [Full Text] [Related]
29. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. Wallemacq P, Goffinet JS, O'Morchoe S, Rosiere T, Maine GT, Labalette M, Aimo G, Dickson D, Schmidt E, Schwinzer R, Schmid RW. Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928 [Abstract] [Full Text] [Related]
30. [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer]. Yargui L, Berhoune A. Ann Biol Clin (Paris); 2008 Apr; 66(6):657-64. PubMed ID: 19091665 [Abstract] [Full Text] [Related]
31. Heterophilic antibody interference in a non-endogenous molecule assay: an apparent elevation in the tacrolimus concentration. Altinier S, Varagnolo M, Zaninotto M, Boccagni P, Plebani M. Clin Chim Acta; 2009 Apr; 402(1-2):193-5. PubMed ID: 19150346 [Abstract] [Full Text] [Related]
34. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus]. Chung JW, An D, Song J, Chung HJ, Park HI, Lee W, Chun S, Min WK. Korean J Lab Med; 2009 Oct; 29(5):415-22. PubMed ID: 19893350 [Abstract] [Full Text] [Related]
38. Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients. Colantonio DA, Borden KK, Clarke W. Clin Biochem; 2007 Jun; 40(9-10):680-7. PubMed ID: 17428457 [Abstract] [Full Text] [Related]
39. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. Wilson D, Johnston F, Holt D, Moreton M, Engelmayer J, Gaulier JM, Luthe H, Marquet P, Moscato D, Oellerich M, Mosso R, Streit F, Brunet M, Fillee C, Schmid R, Wallemacq P, Barnes G. Clin Biochem; 2006 Apr; 39(4):378-86. PubMed ID: 16545357 [Abstract] [Full Text] [Related]
40. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods. Brunet M, Pou L, Torra M, López R, Rodamilans M, Corbella J. Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]